The company is set to unveil two scientific posters at the August 3–6 event, focusing on how its proprietary tAN® technology impacts physiological stress and sleep quality. Michael Darrow, Director of Research Innovations, will lead the presentation on the HAWK device, detailing how the wearable reduces perceived stress and specific biomarkers in high-stakes environments.

Complementing these findings, Chief Science Officer Navid Khodaparast will share results from a decentralized clinical trial involving first responders. This research highlights the potential for daily neurostimulation sessions to mitigate anxiety and bolster sleep resilience. By presenting at the Department of Defense’s premier medical conference, Spark Biomedical aims to move its bioelectronic therapies beyond traditional clinical settings and into the field of operational readiness.